AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 350 filers reported holding AVANOS MED INC in Q4 2018. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,605,226 | +14.0% | 178,300 | +44.1% | 0.01% | +12.5% |
| Q2 2023 | $3,161,772 | -25.5% | 123,700 | -13.3% | 0.01% | -27.3% |
| Q1 2023 | $4,243,898 | -21.5% | 142,700 | -28.5% | 0.01% | -26.7% |
| Q4 2022 | $5,403,882 | +3.8% | 199,700 | -16.5% | 0.02% | 0.0% |
| Q3 2022 | $5,208,000 | -30.6% | 239,100 | -12.8% | 0.02% | -28.6% |
| Q2 2022 | $7,499,000 | -26.5% | 274,300 | -10.0% | 0.02% | -22.2% |
| Q1 2022 | $10,207,000 | -0.8% | 304,700 | +2.6% | 0.03% | +3.8% |
| Q4 2021 | $10,294,000 | +4.6% | 296,900 | -5.9% | 0.03% | 0.0% |
| Q3 2021 | $9,840,000 | +1393.2% | 315,400 | +1988.7% | 0.03% | +1200.0% |
| Q2 2019 | $659,000 | -73.9% | 15,100 | -74.5% | 0.00% | -66.7% |
| Q1 2019 | $2,522,000 | -25.6% | 59,100 | -21.9% | 0.01% | -33.3% |
| Q4 2018 | $3,391,000 | -38.1% | 75,700 | -5.4% | 0.01% | -30.8% |
| Q3 2018 | $5,481,000 | – | 80,017 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 3,087,229 | $96,322,000 | 4.36% |
| RGM Capital, LLC | 2,521,930 | $78,684,000 | 3.86% |
| Tributary Capital Management, LLC | 322,946 | $10,076,000 | 0.78% |
| Alpha Paradigm Partners, LLC | 52,844 | $1,649,000,000 | 0.66% |
| HEARTLAND ADVISORS INC | 307,416 | $9,591,000 | 0.58% |
| Factorial Partners, LLC | 23,400 | $730,000 | 0.50% |
| Champlain Investment Partners, LLC | 2,082,903 | $64,987,000 | 0.31% |
| WESTWOOD HOLDINGS GROUP INC | 741,503 | $23,135,000 | 0.25% |
| Campbell & CO Investment Adviser LLC | 22,100 | $690,000 | 0.22% |
| AIGEN INVESTMENT MANAGEMENT, LP | 26,488 | $826,000 | 0.16% |